BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4613734)

  • 1. Sensitivity of Streptococcus pyogenes to sulphamethoxazole, trimethoprim, and cotrimoxazole.
    Yourassowsky E; Vanderlinden MP; Schoutens E
    J Clin Pathol; 1974 Nov; 27(11):897-901. PubMed ID: 4613734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro sensitivity of hemophilus influenzae and streptococcus pyogenes to co-trimoxazole.
    Leers WD
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):59-63. PubMed ID: 1093653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro resistance of canine staphylococci to trimethoprim and sulphamethoxazole alone and in combination.
    Hinton M; Marston M; Crisfield J
    J Vet Pharmacol Ther; 1981 Mar; 4(1):33-8. PubMed ID: 6984087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
    Obaseiki-Ebor EE
    Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of trimethoprim-sulfamethoxazole resistance in Streptococcus pneumoniae by using the E test with Mueller-Hinton agar supplemented with sheep or horse blood may be unreliable. The Pneumococcal Study Group.
    Lovgren M; Dell'Acqua L; Palacio R; Echániz-Aviles G; Soto-Noguerón A; Castañeda E; Agudelo CI; Heitmann I; Brandileone MC; Zanella RC; Rossi A; Pace J; Talbot JA
    J Clin Microbiol; 1999 Jan; 37(1):215-7. PubMed ID: 9854095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the antibacterial activity of sulphonamide-trimethoprim combinations.
    Fourie ED; van Straten AM; Maritz HC; van Rensburg AJ
    S Afr Med J; 1979 Mar; 55(14):544-7. PubMed ID: 377523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
    Bach MC; Finland M; Gold O; Wilcox C
    J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 9. [Development of bacterial resistance against trimethoprim-sulfamethoxazole (Eusaprim)].
    Meyer-Rohn J; Liehr W
    Fortschr Med; 1974 Jan; 92(3):121-6. PubMed ID: 4206486
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 12. [Susceptibility of Streptococcus pyogenes isolated from invasive infections to trimethoprim-sulfamethoxazole].
    Vigliarolo L; Gazzeli L; Bonofiglio L; Mollerach M; Lopardo H
    Medicina (B Aires); 2018; 78(5):311-314. PubMed ID: 30285923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reappraisal of the antibacterial action of cotrimoxazole in vitro.
    Lewis EL; Anderson JD; Lacey RW
    J Clin Pathol; 1974 Feb; 27(2):87-91. PubMed ID: 4596417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity testing with trimethorpim-sulphamethoxazole.
    Bushby SR
    Med J Aust; 1973 Jun; 1(2):Suppl:10-8. PubMed ID: 4199527
    [No Abstract]   [Full Text] [Related]  

  • 15. Trimethoprim, sulphamethoxazole, bacterial adhesion and polymorphonuclear leucocyte function.
    Emmanouilides CE; Lianou PE; Bassaris HP; Papavassiliou JT
    J Antimicrob Chemother; 1990 Dec; 26(6):803-12. PubMed ID: 2081720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activity of gentamicin with trimethoprim or sulfamethoxazole-trimethoprim against Escherichia coli and Klebsiella pneumoniae.
    Paisley JW; Washington JA
    Antimicrob Agents Chemother; 1978 Nov; 14(5):656-8. PubMed ID: 365085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?
    Bowen AC; Lilliebridge RA; Tong SY; Baird RW; Ward P; McDonald MI; Currie BJ; Carapetis JR
    J Clin Microbiol; 2012 Dec; 50(12):4067-72. PubMed ID: 23052313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vitro sensitivity testing methods of detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay.
    Rawal BD; Cottis L
    Arzneimittelforschung; 1980; 30(7):1049-51. PubMed ID: 6998489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative susceptibility testing to sulfamethoxazole and trimethoprim by agar diffusion test on different media (author's transl)].
    Freiesleben H; Marre R
    Immun Infekt; 1978 Dec; 6(6):223-5. PubMed ID: 365716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.
    Bushby SR
    J Infect Dis; 1973 Nov; 128():Suppl:442-62 p. PubMed ID: 4585951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.